Variant report

Variant	nsv975986
Chromosome Location	chr11:121106081-121115293
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:224)
CpG islands
(count:61)
Chromatin interactive
region (count:2)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:224 , 50 per page) page: 1 2 3 4 5

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr11:121106613-121108463	GM12878	blood:	n/a	n/a
2	ATF2	chr11:121106770-121107212	GM12878	blood:	n/a	n/a
3	ATF2	chr11:121107870-121108382	GM12878	blood:	n/a	n/a
4	BATF	chr11:121106773-121107269	GM12878	blood:	n/a	chr11:121107013-121107024
5	BATF	chr11:121107897-121108448	GM12878	blood:	n/a	n/a
6	BATF	chr11:121107315-121107624	GM12878	blood:	n/a	n/a
7	BATF	chr11:121106765-121107164	GM12878	blood:	n/a	chr11:121107013-121107024
8	BATF	chr11:121107909-121108346	GM12878	blood:	n/a	n/a
9	BATF	chr11:121108683-121109269	GM12878	blood:	n/a	n/a
10	BATF	chr11:121108727-121109060	GM12878	blood:	n/a	n/a
11	BCL11A	chr11:121107868-121108345	GM12878	blood:	n/a	n/a
12	BCL11A	chr11:121107954-121108320	GM12878	blood:	n/a	n/a
13	BCL11A	chr11:121108685-121109034	GM12878	blood:	n/a	n/a
14	BCL11A	chr11:121108704-121109088	GM12878	blood:	n/a	n/a
15	BCL11A	chr11:121106734-121107216	GM12878	blood:	n/a	n/a
16	BCL3	chr11:121106738-121107264	GM12878	blood:	n/a	n/a
17	BCLAF1	chr11:121107953-121108382	GM12878	blood:	n/a	n/a
18	BCLAF1	chr11:121107871-121108454	GM12878	blood:	n/a	n/a
19	BHLHE40	chr11:121107354-121107356	K562	blood:	n/a	n/a
20	BHLHE40	chr11:121106768-121107583	GM12878	blood:	n/a	n/a
21	BHLHE40	chr11:121107986-121108263	GM12878	blood:	n/a	n/a
22	CHD1	chr11:121108937-121108941	GM12878	blood:	n/a	n/a
23	CHD1	chr11:121108149-121108346	GM12878	blood:	n/a	n/a
24	CHD1	chr11:121107605-121107611	GM12878	blood:	n/a	n/a
25	CHD2	chr11:121108480-121108522	GM12878	blood:	n/a	n/a
26	CHD2	chr11:121108071-121108271	GM12878	blood:	n/a	n/a
27	CHD2	chr11:121108769-121108983	GM12878	blood:	n/a	n/a
28	CTCF	chr11:121108181-121108272	GM19238	blood:	n/a	n/a
29	CTCF	chr11:121111560-121111710	BE2_C	brain:	n/a	n/a
30	CTCF	chr11:121108518-121108554	GM19240	blood:	n/a	n/a
31	CTCF	chr11:121108161-121108289	GM12878	blood:	n/a	n/a
32	CTCF	chr11:121108140-121108290	GM06990	blood:	n/a	n/a
33	CTCF	chr11:121108840-121108990	AG10803	skin:	n/a	n/a
34	CTCF	chr11:121108430-121108558	GM12892	blood:	n/a	n/a
35	CTCF	chr11:121108464-121108530	GM12891	blood:	n/a	n/a
36	CTCF	chr11:121108838-121108890	GM20000	blood:	n/a	n/a
37	CTCF	chr11:121112342-121112395	H1-hESC	embryonic stem cell:	n/a	n/a
38	CTCF	chr11:121108140-121108290	GM12873	blood:	n/a	n/a
39	CTCF	chr11:121108880-121109030	HEEpiC	esophagus:	n/a	n/a
40	CTCF	chr11:121108432-121108542	GM19238	blood:	n/a	n/a
41	CTCF	chr11:121108395-121108539	GM19239	blood:	n/a	n/a
42	CTCF	chr11:121108620-121108770	GM12873	blood:	n/a	n/a
43	CTCF	chr11:121108900-121109050	GM12865	blood:	n/a	n/a
44	CTCF	chr11:121108940-121109090	SAEC	small airway:	n/a	n/a
45	CTCF	chr11:121108183-121108261	GM12892	blood:	n/a	n/a
46	CTCF	chr11:121108120-121108270	GM12873	blood:	n/a	n/a
47	CTCF	chr11:121108940-121109090	AG10803	skin:	n/a	n/a
48	CTCF	chr11:121109118-121109183	Pancreas_OC	pancreas:	n/a	n/a
49	CTCF	chr11:121108155-121108295	GM19239	blood:	n/a	n/a
50	CTCF	chr11:121108071-121108985	GM12878	blood:	n/a	chr11:121108813-121108821

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:121112773-121112823	NH-A	brain:	n/a
2	chr11:121112773-121112823	HCM	heart:	n/a
3	chr11:121112773-121112823	HRPEpiC	eye:	n/a
4	chr11:121112773-121112823	AG09319	gingival:	n/a
5	chr11:121112773-121112823	LNCaP	prostate:	n/a
6	chr11:121112773-121112823	ProgFib	skin:	n/a
7	chr11:121112773-121112823	GM12892	blood:	n/a
8	chr11:121112773-121112823	HCT-116	colon:	n/a
9	chr11:121112773-121112823	BJ	skin:	n/a
10	chr11:121112773-121112823	HAEpiC	amniotic membrane:	n/a
11	chr11:121112773-121112823	H1-hESC	embryonic stem cell:	embryo
12	chr11:121112773-121112823	Caco-2	colon:	n/a
13	chr11:121112773-121112823	NHDF-neo	bronchial:	n/a
14	chr11:121112773-121112823	HCF	heart:	n/a
15	chr11:121112773-121112823	HepG2	liver:	n/a
16	chr11:121112773-121112823	IMR90	lung:	fetal
17	chr11:121112773-121112823	PANC-1	pancreas:	n/a
18	chr11:121112773-121112823	PrEC	prostate:	n/a
19	chr11:121112773-121112823	CMK	blood:	n/a
20	chr11:121112773-121112823	AoSMC	blood vessel:	n/a
21	chr11:121112773-121112823	HNPCEpiC	eye:	n/a
22	chr11:121112773-121112823	Hepatocyte	liver:	n/a
23	chr11:121112773-121112823	U87	brain:	n/a
24	chr11:121112773-121112823	T-47D	breast:	n/a
25	chr11:121112773-121112823	NHBE	bronchial:	n/a
26	chr11:121112773-121112823	RPTEC	kidney:	n/a
27	chr11:121112773-121112823	BE2_C	brain:	n/a
28	chr11:121112773-121112823	GM12891	blood:	n/a
29	chr11:121112773-121112823	HMEC	breast:	n/a
30	chr11:121112773-121112823	PFSK-1	brain:	n/a
31	chr11:121112773-121112823	HUVEC	blood vessel:	n/a
32	chr11:121112773-121112823	HEK293	kidney:	embryo
33	chr11:121112773-121112823	AG10803	skin:	n/a
34	chr11:121112773-121112823	ECC-1	luminal epithelium:	n/a
35	chr11:121112773-121112823	AG04450	lung:	fetal
36	chr11:121112773-121112823	A549	lung:	n/a
37	chr11:121112773-121112823	HEEpiC	esophagus:	n/a
38	chr11:121112773-121112823	GM12878	blood:	n/a
39	chr11:121112773-121112823	HL-60	blood:	n/a
40	chr11:121112773-121112823	SKMC	muscle:	n/a
41	chr11:121112773-121112823	HPAEpiC	pulmonary alveolar:	n/a
42	chr11:121112773-121112823	AG04449	skin:	fetal
43	chr11:121112773-121112823	AG09309	skin:	n/a
44	chr11:121112773-121112823	HIPEpiC	eye:	n/a
45	chr11:121112773-121112823	HCPEpiC	choroid plexus:	n/a
46	chr11:121112773-121112823	MCF10A-Er-Src	breast:	n/a
47	chr11:121112773-121112823	HRE	kidney:	n/a
48	chr11:121112773-121112823	GM06990	blood:	n/a
49	chr11:121112773-121112823	NB4	blood:	n/a
50	chr11:121112773-121112823	SK-N-SH	brain:	n/a

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr11:121096484..121098779-chr11:121104853..121107666,2	K562	blood:
2	chr11:121097383..121099804-chr11:121109722..121112130,2	K562	blood:

No data

Variant related genes	Relation type
ENSG00000254515	TF binding region
ENSG00000254515	CpG island

Extended variants
information (count: 412 )
Associated
traits (count: 95 )

Variant overlapped rSNPs/rCNVs (count:412 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs71486363	chr11:121106150-121106151	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs2847386	chr11:121106156-121106157	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs561382605	chr11:121106187-121106188	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs151050249	chr11:121106196-121106197	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs540803780	chr11:121106249-121106250	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs146942782	chr11:121106261-121106262	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs200145277	chr11:121106262-121106263	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs57682616	chr11:121106293-121106294	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs565495650	chr11:121106294-121106295	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs11600741	chr11:121106359-121106360	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs550826110	chr11:121106386-121106387	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs569235351	chr11:121106450-121106451	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs141354288	chr11:121106451-121106452	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs548563649	chr11:121106454-121106455	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs375316603	chr11:121106456-121106457	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs75370984	chr11:121106457-121106458	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs369909091	chr11:121106483-121106484	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs145102803	chr11:121106540-121106541	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs571135170	chr11:121106548-121106549	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs7108971	chr11:121106570-121106571	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
21	rs117015720	chr11:121106631-121106632	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs75335512	chr11:121106642-121106643	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs553993897	chr11:121106692-121106693	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs542212823	chr11:121106738-121106739	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs192100180	chr11:121106752-121106753	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs573544452	chr11:121106778-121106779	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs577219714	chr11:121106799-121106800	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs540963317	chr11:121106855-121106856	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs565459598	chr11:121107003-121107004	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs139040011	chr11:121107071-121107072	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs544687002	chr11:121107100-121107101	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs562803993	chr11:121107135-121107136	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs184408289	chr11:121107141-121107142	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs548252315	chr11:121107150-121107151	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs190730193	chr11:121107155-121107156	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs533099907	chr11:121107163-121107164	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs181936013	chr11:121107182-121107183	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs572298534	chr11:121107191-121107192	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs571099286	chr11:121107232-121107233	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs538415485	chr11:121107241-121107242	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs186132761	chr11:121107248-121107249	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs568831064	chr11:121107249-121107250	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs189149305	chr11:121107271-121107272	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs536363860	chr11:121107272-121107273	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs7129197	chr11:121107345-121107346	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs572905701	chr11:121107365-121107366	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs534494720	chr11:121107421-121107422	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs7129335	chr11:121107473-121107474	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs181274903	chr11:121107488-121107489	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs544987840	chr11:121107492-121107493	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:95)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Multiple myeloma	20724749	CNVD
Wilms tumour	21544195	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Acute myeloid leukemia	20729466	CNVD
Cancer	21637783	CNVD
Acute myeloid leukemia	16864856	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21484798	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Cervical cancer	21063398	CNVD
Glioblastoma multiforme	19960244	CNVD
Liposarcoma	21253554	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Neuroblastoma	17533364	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Cancer	16751803	CNVD
Seminomas	18059402	CNVD
Cervical cancer	21062161	CNVD
Esophageal squamous carcinoma	18350619	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Neuroblastoma	18923191	CNVD
Glioblastoma multiforme	21080181	CNVD
Cancer	22429812	CNVD
Breast cancer	16608533	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
T-cell lymphomas	19863542	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Basal cell lymphoma	17053054	CNVD
Hepatocellular carcinoma	16785998	CNVD
Breast cancer	21858162	CNVD
Breast cancer	21785460	CNVD
Acute myeloid leukemia	21251322	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Breast cancer	21958427	CNVD
Lung cancer	18438408	CNVD
Ewing''s sarcoma	17952124	CNVD
Breast cancer	17133270	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	17603634	CNVD
Breast cancer	21364760	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Ovarian cancer	21720365	CNVD
Neuroblastoma	17327916	CNVD
Malignant melanoma	17260012	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Prostate cancer	16573809	CNVD
Prostate cancer	18632612	CNVD
Renal cell carcinoma	21668985	CNVD
Developmental delay	21147756	CNVD
Squamous cell cancer	20885788	CNVD
Renal cell carcinoma	18765545	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Neurocytoma	17123091	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Central neurocytomas	17123091	CNVD
Congenital diaphragmatic hernia	21525063	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Multiple myeloma	16616336	CNVD
Hepatocellular carcinoma	16750200	CNVD
Multiple myeloma	17550852	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
Acute myeloid leukemia	19651601	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Breast cancer	20409316	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Heart disease	20551144	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Breast cancer	21509527	CNVD
Barrett''s syndrome	19417022	CNVD
Myelofibrosis	22110671	CNVD
Cancer	21183584	CNVD
Non-small cell lung cancer	21385341	CNVD
Multiple myeloma	16461302	CNVD
Burkitt''s lymphoma	18698080	CNVD
Prostate cancer	23792589	CNVD

Chromatin state (count:226 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:121100600-121107600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
2	chr11:121102000-121107000	Weak transcription	Fetal Intestine Small	intestine
3	chr11:121102800-121107400	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
4	chr11:121102800-121107400	Weak transcription	Right Atrium	heart
5	chr11:121103000-121106800	Weak transcription	Fetal Intestine Large	intestine
6	chr11:121103000-121107400	Weak transcription	Gastric	stomach
7	chr11:121103000-121107600	Weak transcription	Pancreas	Pancrea
8	chr11:121104400-121107000	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
9	chr11:121104400-121108600	Enhancers	HUES64 Cell Line	embryonic stem cell
10	chr11:121104400-121109000	Enhancers	ES-I3 Cell Line	embryonic stem cell
11	chr11:121104400-121110600	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
12	chr11:121104600-121106400	Enhancers	iPS-20b Cell Line	embryonic stem cell
13	chr11:121104600-121106800	Enhancers	iPS-15b Cell Line	embryonic stem cell
14	chr11:121104600-121108800	Enhancers	HUES6 Cell Line	embryonic stem cell
15	chr11:121104600-121109400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
16	chr11:121104600-121110000	Enhancers	HUES48 Cell Line	embryonic stem cell
17	chr11:121104600-121110200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
18	chr11:121104600-121113200	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
19	chr11:121104800-121107000	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
20	chr11:121104800-121108000	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
21	chr11:121104800-121109200	Enhancers	iPS-18 Cell Line	embryonic stem cell
22	chr11:121104800-121113200	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
23	chr11:121105000-121106800	Weak transcription	H1 Cell Line	embryonic stem cell
24	chr11:121105200-121107000	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
25	chr11:121105400-121108400	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
26	chr11:121105600-121106400	Enhancers	HSMMtube	muscle
27	chr11:121105600-121107800	Enhancers	Fetal Heart	heart
28	chr11:121105600-121112800	Enhancers	Fetal Muscle Leg	muscle
29	chr11:121105800-121106200	Enhancers	GM12878-XiMat	blood
30	chr11:121105800-121106600	Enhancers	Breast Myoepithelial Primary Cells	Breast
31	chr11:121105800-121107600	Enhancers	HSMM	muscle
32	chr11:121105800-121109000	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
33	chr11:121105800-121113800	Enhancers	Muscle Satellite Cultured Cells	--
34	chr11:121106000-121107000	Weak transcription	H9 Cell Line	embryonic stem cell
35	chr11:121106000-121107800	Enhancers	Liver	Liver
36	chr11:121106000-121110200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
37	chr11:121106200-121106600	Bivalent Enhancer	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
38	chr11:121106200-121107800	Flanking Active TSS	GM12878-XiMat	blood
39	chr11:121106400-121106600	Flanking Active TSS	HSMMtube	muscle
40	chr11:121106400-121107200	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
41	chr11:121106600-121106800	Enhancers	HSMMtube	muscle
42	chr11:121106600-121110400	Weak transcription	Breast Myoepithelial Primary Cells	Breast
43	chr11:121106600-121112800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
44	chr11:121106800-121107000	Flanking Active TSS	HSMMtube	muscle
45	chr11:121106800-121107200	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
46	chr11:121106800-121107200	Enhancers	Duodenum Mucosa	Duodenum
47	chr11:121106800-121107200	Enhancers	Fetal Intestine Large	intestine
48	chr11:121106800-121108000	Enhancers	H1 Cell Line	embryonic stem cell
49	chr11:121106800-121108200	Enhancers	Primary B cells from peripheral blood	blood
50	chr11:121106800-121108400	Enhancers	Aorta	Aorta

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links